Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature

S Wolking, E Schaeffeler, H Lerche, M Schwab… - Clinical …, 2015 - Springer
ATP-binding cassette transporter B1 (ABCB1; P-glycoprotein; multidrug resistance protein 1)
is an adenosine triphosphate (ATP)-dependent efflux transporter located in the plasma …

Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition

SF Zhou - Xenobiotica, 2008 - Taylor & Francis
1. P-glycoprotein (P-gp/MDR1), one of the most clinically important transmembrane
transporters in humans, is encoded by the ABCB1/MDR1 gene. Recent insights into the …

PharmGKB summary: cyclosporine and tacrolimus pathways

JM Barbarino, CE Staatz… - Pharmacogenetics …, 2013 - journals.lww.com
Tacrolimus (FK506) and cyclosporine (cyclosporin A, CsA) are cornerstone
immunosuppressive agents administered to solid organ transplant recipients to prevent and …

Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance

O Bruhn, I Cascorbi - Expert opinion on drug metabolism & …, 2014 - Taylor & Francis
Introduction: Human ATP-binding cassette (ABC) transporters act as translocators of
numerous substrates across extracellular and intracellular membranes, thereby contributing …

P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations

I Cascorbi - Drug transporters, 2011 - Springer
Abstract P-glycoprotein (ABCB1, MDR1) belongs to the ABC transporter family transporting
a wide range of drugs and xenobiotics from intra-to extracellular at many biological …

ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?

H Bruckmueller, I Cascorbi - Expert opinion on drug metabolism & …, 2021 - Taylor & Francis
Introduction Interindividual differences in drug response are a frequent clinical challenge
partly due to variation in pharmacokinetics. ATP-binding cassette (ABC) transporters are …

Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer

S Cotino-Nájera, LA Herrera… - Frontiers in …, 2023 - frontiersin.org
One of the primary diseases that cause death worldwide is cancer. Cancer cells can be
intrinsically resistant or acquire resistance to therapies and drugs used for cancer treatment …

CYP3A5 and ABCB1 Polymorphisms Influence Tacrolimus Concentrations in Peripheral Blood Mononuclear Cells After Renal Transplantation

A Capron, M Mourad, M De Meyer, L De Pauw… - …, 2010 - Taylor & Francis
Aims: This prospective study investigated the effect of genetic polymorphisms in a
biotransformation enzyme (CYP3A5) and a transporter protein (ABCB1) on tacrolimus (Tac) …

Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia

J Gregers, H Green, IJ Christensen, K Dalhoff… - The …, 2015 - nature.com
The membrane transporter P-glycoprotein, encoded by the ABCB1 gene, influences the
pharmacokinetics of anti-cancer drugs. We hypothesized that variants of ABCB1 affect …

Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients

S Crettol, JP Venetz, M Fontana… - Pharmacogenetics …, 2008 - journals.lww.com
Objective The expression on lymphocytes of P-glycoprotein, an efflux transporter encoded
by the ABCB1 gene, might influence cyclosporine intracellular concentration. Methods …